Working With Healthcare Leaders
Cernostics works collaboratively with leading scientists and clinicians in fields such as molecular/cellular imaging, computational biology, gastroenterology, pathology, and surgery. Our collaborators provide insight and guidance to our overall research and development activities, and directly participate in our ongoing mission to develop new methods for preventing the development of cancer.
Cernostics continues to look for new collaborators and partners to expand the use of its technology platform. If you are interested in learning more about partnership opportunities, please Contact Us.
Academic Medical Center, Amsterdam, The Netherlands
Jacques Bergman, MD, PhD
Dr. Bergman is currently Professor of Gastroenterology Endoscopy, and Head of Esophageal Research at Academic Medical Center in Amsterdam, The Netherlands. Dr. Bergman undertook his PhD-training, dedicated to the endoscopic management of gallstone disease, in Amsterdam. He was trained in Gastroenterology in Den Bosch and Amsterdam and was appointed Consultant Gastroenterologist, at Academic Medical Center in Amsterdam in 2001 and appointed as Associate Professor in 2005. Since June 2011 he has been a professor of Gastrointestinal Endoscopy at the University of Amsterdam. Additionally, he is the head of the AMC esophageal research team, which conducts endoscopic imaging studies. Dr. Bergman is a permanent member of International Working Group on Classification of Oesophagitis, Co-editor and member of the International Editorial board of "Endoscopy" and is the secretary of the Dutch Society of Gastrointestinal Endoscopy. Dr. Bergman has authored and co-authored on over 140 peer reviewed publications and text book chapters and has lectured at many national and international meetings.
Prisma Analytics, LLC.
Mauro Maggioni, PhD
Mauro Maggioni is a Professor of Mathematics, Computer Science, Electrical and Computer Engineering at Duke University specializing in High-Dimensional Probability and Statistics - Computational Harmonic Analysis - Signal Processing - Machine Learning and Spectral Graph Theory. His recent work has focused on the construction of multi-resolution structures on discrete data and graphs, connecting aspects of classical harmonic analysis, global analysis on manifolds, spectral graph theory and classical multiscale analysis. These ideas enable multiscale signal processing on graphs and manifolds, with a wide variety of applications to analysis of data, compression and denoising, classification and clustering algorithms for images (e.g.: 2-D, hyper-spectral), EEG data, network traffic, large data sets. In 2002, Dr. Maggioni received a Ph.D. in Mathematics, from Washington University, St.Louis, Discretization of continuous wavelet transforms, advisor: Prof. G. L. Weiss. Area: harmonic analysis.
Geisinger Health System, Danville, PA
Jinhong Li, MD, PhD
Dr. Li received his M.D. from Binzhou Medical College, P. R. China. He also holds a Master's degree in Pathophysiology from Xi'an Medical University, P. R. China, and a Ph.D. in Physiology from Georgetown University, Washington, DC. He completed postdoctoral fellowship training at Harvard University and Massachusetts General Hospital, Boston, Mass. Dr. Li received his pathology residency training at Brown University and Rhode Island Hospital and completed fellowships in surgical pathology with a subspecialty in genitourinary pathology at the University of Pennsylvania and in gastrointestinal and liver pathology at Emory University Hospital in Atlanta, Georgia. Dr. Li is board certified in anatomic and clinical pathology. His areas of specialization include gastrointestinal and liver pathology, urologic/genitourinary pathology, soft tissue and bone, and thyroid pathology.
Jeffrey Prichard, DO
Dr. Prichard is currently Director of Surgical Pathology at Geisinger Health System, with research interests in anatomic pathology and medical informatics, image analysis, and quantitative immunohistochemistry. Dr. Prichard received his DO from Kirksville College of Osteopathic Medicine in Kirksville, Missouri, and completed an internship at Metro Health Center in Erie, PA. He performed his residency in anatomic and clinical pathology and fellowship training in anatomic pathology at Allegheny General Hospital in Pittsburgh. Board-certified by the American Board of Pathology in both anatomic and clinical pathology, as well as by the National Board of Osteopathic Medical Examiners, Dr. Prichard specializes in breast and noncervical gynecologic pathology, liver pathology, and renal pathology. He is a member of the American Association of Clinical Scientists, College of American Pathologists.
David Diehl, MD, FACP, FASGE
Dr. Diehl is Director of Interventional Endoscopy and the Center for Advanced Endoscopic Research and Training at Geisinger Health System. Prior to joining Geisinger, he was on the faculty of NYU School of Medicine in the Division of Gastroenterology. He was previously on staff at UCLA School of Medicine. He is proficient in all advanced endoscopic techniques; most relevant to his collaboration with Cernostics are endoscopic ultrasound, endoscopic mucosal resection, and Barrett's ablation. He attended undergraduate and medical school at the University of California, Los Angeles. Prior to clinical training in internal medicine, Dr. Diehl completed a year of pathology residency which included extensive training in anatomic pathology. His clinical gastroenterology training was at UC San Francisco, followed by basic science research at UCLA. Dr. Diehl is currently Clinical Professor of Medicine affiliated with Temple University School of Medicine, and maintains an Adjunct Clinical Associate Professor of Medicine with NYU School of Medicine.
University of Pennsylvania, Philadelphia, PA
Gary Falk, MD, MS
Dr. Falk is currently Professor of Medicine at the Hospital for the University of Pennsylvania, and Clinical Co-Director Clinical Co-Director, Joint Center for Digestive, Liver and Pancreatic Medicine, at the University of Pennsylvania School of Medicine and the Children's Hospital of Philadelphia . A graduate of the University of Rochester School of Medicine. Dr. Falk completed his internship and residency in internal medicine at George Washington University Medical Center. This was followed by a clinical and research fellowship in gastroenterology at the University of Michigan Medical Center. He previously served the Department of Gastroenterology and Hepatology at the Cleveland Clinic for the past 23 years. While in Cleveland, he received his Masters in Clinical Research. Dr. Falk is nationally and internationally recognized for treating esophageal diseases, including achalasia, eosinophilic esophagitis, gastroesophageal reflux disease, swallowing disorders and, Barrett's esophagus. He has served as President of the American Society for Gastrointestinal Endoscopy, and is a member of several national societies. He has published extensively in leading journals and is board certified in internal medicine and gastroenterology.
Nirag C. Jhala, MD
Dr. Jhala is a Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. His clinical activities and research focus on the application of endoscopic ultrasound based fine needle aspiration specimens for the diagnostic classification of pancreatico- biliary lesions. He is associate editor of Cytojournal and a member of the editorial boards of Archives of Pathology and Laboratory Medicine, Journal of Histochemistry and Cytochemistry and Clinical Gastroenterology and Hepatology. He is also a member of an NIH grant review panel. He is a member of a number of national and international professional and scientific societies, and currently serves on the Training Committee of the Rodger C. Haggitt Gastrointestinal Tract Pathology Society and the Education Oversight Committee of the American Society of Cytology.Dr. Jhala is board certified in Cytopathology he is a graduate of B.J. Medical College, Ahmedabad.
Anil Rustgi, MD
Dr. Rustgi is currently Chief of Gastroenterology in the Department of Medicine, and the T. Grier Miller Professor of Medicine and Genetics at the University of Pennsylvania. He is the current President of the American Gastroenterology Association. As a leader in the field of GI cancer research, Dr. Rustgi has made seminal contributions to understanding the mechanisms underlying the development of several major GI cancers, notably esophageal, pancreatic and colorectal cancers. His research is funded through the NIH and other sources. He serves on the advisory boards of the National Colorectal Cancer Research Alliance, Pancreatic Cancer Action Network, National Pancreas Foundation and Caring for Carcinoid Foundation. Dr. Rustgi is an active clinician in the care of patients, especially with GI cancers and genetic disorders. Dr. Rustgi's research is in the molecular genetics of GI cancers, including those originating from the esophagus/head and neck, pancreas and colon. His work has focused upon the role of oncogenes and tumor suppressor genes in tumor initiation and progression, and the role of the tumor microenvironment as well.
University of Pittsburgh, Pittsburgh, PA
Charkra Chennubhotla, PhD
Dr. Chennubhotla is an Assistant Professor in the Department of Computational and Systems Biology at the School of Medicine, University of Pittsburgh. My research focuses on issues in structural biology and bioimaging, with an emphasis on understanding molecular basis of enzyme function, establishing organizational principles for conformational ensembles, mining molecular dynamics simulations for biologically relevant substates and automated reconstruction of neuronal structure from histological data. He received his Ph.D. from the University of Toronto with a Thesis in Spectral Methods for Multi-Scale Feature Extraction and Data Clustering.
Jon Davison, MD
Dr. Davison is currently Assistant Professor of Medicine within the Division of Anatomic Pathology at the University of Pittsburgh Medical Center. He is also a member of the Gastrointestinal Pathology Center of Excellence. His primary research is in the clinical, pathologic and molecular determinants of the behavior and outcomes of esophageal carcinoma and Barrett's esophagus. Dr. Davison received his MD from Pritzker School of Medicine at the University of Chicago in 2002.
Lans Taylor, PhD (Scientific Advisor and Co-Founder of Cernostics)
Dr. Taylor is currently Director, University of Pittsburgh Drug Discovery Institute & Allegheny Foundation Professor of Computational and Systems Biology. As Director of the Drug Discovery Institute, he works with both academic and commercial collaborators to discover and develop efficacious and safe therapeutics based on the integration of outstanding science, technology and drug discovery/development methods. Dr. Taylor is a co-founder and scientific advisor to Cernostics, starting the company based on the vision of applying systems biology approaches to fundamental tissue diagnostics and anatomic pathology. Prior to founding Cernostics, Dr. Taylor founded multiple life science companies including Biological Detection Systems (acquired by Amersham), Cellomics (acquired by ThermoFisher), and Cellumen. Dr. Taylor holds more than 25 U.S. patents, including six focused on cell-based imaging. His academic career has included positions at Harvard University and Carnegie Mellon University, where he was awarded multiple accolades for his work including a NIH MERIT award from 1990-2000 and a Pioneer Award from the National Science Foundation.
West Penn Allegheny Health System, Pittsburgh, PA
Blair Jobe, MD
Dr. Jobe is currently Chief of Surgery, and Director of the Institute for the Treatment of Esophageal and Thoracic Disease at West Penn Allegheny Health System in Pittsburgh, PA. Previously Dr. Jobe was the Sampson Endowed Professor of Surgery at the University of Pittsburgh School of Medicine and has served as the director of esophageal research and esophageal diagnostics and therapeutic endoscopy at the UPMC Heart, Lung and Esophageal Surgery Institute since 2008. He also is a core member of the research faculty at the UPMC McGowan Institute for Regenerative Medicine.
Dr. Jobe is widely considered one of the country's leading specialists and pioneers in the field of minimally invasive surgery and endoscopic therapy for the treatment of esophageal cancer, Barrett's esophagus, esophageal motility disorders and gastroesophageal reflux disease (GERD). At UPMC, he created the Esophageal Diagnostic Center, a program designed to provide cutting edge diagnostic and therapeutic options for complex esophageal and gastric disorders, and developed the Barrett's Esophagus Risk Consortium, a highly successful NIH-funded cancer and Barrett's screening program.
Ali Zaidi, MD
Dr. Zaidi is the Director of Esophageal and Thoracic Research Laboratories at the Allegheny - Singer Research Institute, Allegheny Health Network (AHN). His research is focused on biomarkers for early detection, risk stratification and targeted therapy. A major part of his current work has been to successfully develop heterotransplant and surgical models of esophageal adenocarcinoma. Dr. Zaidi is also involved with various biomarker outcome studies. Prior to his work at West Penn, Dr. Zaidi held research and faculty positions at the University of Pittsburgh.